Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volasertib vs Chemotherapy in Platinum-Resistant Ovarian Cancer
NCT01121406Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2010
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of volasertib in ovarian cancer, sponsored by Boehringer Ingelheim. Started Apr 2010; status: completed.
02
Drugs
volasertib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01121406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121406.